Abstract:This study introduces a spatially differential plasmid DNA dual‐delivery nano hydrogel conduit fabricated with HA‐GMA/PEI (HP) for restoring extensive segmental nerve defects. It utilizes transforming growth factor β(TGF‐β) delivery via HP (TGF‐β@HP) in the proximal region to enhance nerve regeneration and nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) via HP (NMNAT2@HP) in the distal region to prevent Wallerian degeneration. The design promotes selective nerve fiber alignment, aiming for improved neuromotor and sensory function recovery. Peripheral nerve deficits give rise to motor and sensory impairments within the limb. The clinical restoration of extensive segmental nerve defects through autologous nerve transplantation often encounters challenges such as axonal mismatch and suboptimal functional recovery. These issues may stem from the limited regenerative capacity of proximal axons and the subsequent Wallerian degeneration of distal axons. To achieve the integration of sensory and motor functions, a spatially differential plasmid DNA (pDNA) dual‐delivery nanohydrogel conduit scaffold is devised. This innovative scaffold facilitates the localized administration of the transforming growth factor β (TGF‐β) gene in the proximal region to accelerate nerve regeneration, while simultaneously delivering nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) to the distal region to mitigate Wallerian degeneration. By promoting autonomous and selective alignment of nerve fiber gap sutures via structure design, the approach aims to achieve a harmonious unification of nerve regeneration, neuromotor function, and sensory recovery. It is anticipated that this groundbreaking technology will establish a robust platform for gene delivery in tissue engineering.

Direct Reprogramming of Mouse Fibroblasts into Neural Cells Via Porphyra Yezoensis Polysaccharide Based High Efficient Gene Co-Delivery

Neural Differentiation of Fibroblasts Induced by Intracellular Co-Delivery of Ascl1, Brn2 and FoxA1 Via a Non-Viral Vector of Cationic Polysaccharide

Highly Effective Stroke Therapy Enabled by Genetically Engineered Viral Nanofibers

Direct Reprogramming of Mouse Fibroblasts to Neural Progenitors

Highly Branched Poly(β-Amino Ester) Delivery of Minicircle DNA for Transfection of Neurodegenerative Disease Related Cells

Direct Conversion of Dermal Fibroblasts into Neural Progenitor Cells by a Novel Cocktail of Defined Factors.

Selective Generation of Dopaminergic Precursors from Human Fibroblasts by Direct Lineage Conversion

Conversion of Mouse Fibroblasts into Oligodendrocyte Progenitor-Like Cells Through a Chemical Approach.

Chemical Conversion of Mouse Fibroblasts into Functional Dopaminergic Neurons

Progress and Challenges of Cell Replacement Therapy for Neurodegenerative Diseases Based on Direct Neural Reprogramming

Pharmacological Reprogramming of Fibroblasts into Neural Stem Cells by Signaling-Directed Transcriptional Activation

Direct Reprogramming of Mouse Fibroblasts to Neural Stem Cells by Small Molecules

GDNF gene delivery via a 2-(dimethylamino)ethyl methacrylate based cyclized knot polymer for neuronal cell applications.

Direct Conversion of Mouse Fibroblasts to Gabaergic Neurons with Combined Medium Without the Introduction of Transcription Factors or Mirnas

Direct Reprogramming of Human Fibroblasts into Dopaminergic Neuron-Like Cells

Highly Bioadaptable Hybrid Conduits with Spatially Bidirectional Structure for Precision Nerve Fiber Regeneration via Gene Therapy

Generation of Patient-Specific Induced Neuronal Cells Using A Direct Reprogramming Strategy

Selective Generation of Dopaminergic Precursors from Mouse Fibroblasts by Direct Lineage Conversion

Direct Reprogramming of Fibroblasts into Neural Stem Cells by Single Non-Neural Progenitor Transcription Factor Ptf1a

Delivery of cationic polymer-siRNA nanoparticles for gene therapies in neural regeneration.

Direct Conversion of Normal and Alzheimer’s Disease Human Fibroblasts into Neuronal Cells by Small Molecules